⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 5, 2024Open Access

Willingness to Use Long-acting Injectable Pre-exposure Prophylaxis Among Key Populations at a Large Hiv Prevention Clinic in Kampala, Uganda: a Cross-sectional Study

Jonathan Derrick Lukubuya Elizabeth Katana Micheal Baguma Andrew Kaguta Winnie Nambatya Peter Kyambadde Timothy R. Muwonge Andrew Mujugira Eva Agnes Laker Odongpiny

View Full Paper

Ask AI

Bookmark

Share

Abstract

Long-acting injectable (LAI)-PrEP provides better protection against HIV compared to oral PrEP, which requires taking a daily pill. Our study aimed to assess knowledge about oral and LAI-PrEP and identify factors associated with willingness to use LAI-PrEP among key populations (KP) in Uganda.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lukubuya et al. (2024) studied this question.

synapsesocial.com/papers/68e5d779b6db64358756d0dd https://doi.org/10.21203/rs.3.rs-4719964/v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Brief communication: awareness, knowledge, and attitudes towards long-acting injectable HIV pre-exposure prophylaxis among high-risk female university students in UgandaCross-Sectional Study · 2026
2Hypothetical Preferences and Concerns for Long-Acting Injectable HIV PrEP Use Among Female Barmaids in Ubungo, Dar Es Salaam, Tanzania2025
3Acceptability and Preferences of Long-Acting Injectable Pre-Exposure Prophylaxis and Antiretroviral Therapy Among Men Who Have Sex With Men and People Who Inject Drugs in India: Insights for Future Implementation.Cross-Sectional Study · 2026
4What, how, and when matters: acceptability and preferences for HIV pre-exposure prophylaxis among people who inject drugs in New Delhi, IndiaCross-Sectional Study · 2026
5Exploring HIV prevention preferences among key populations in Uganda: A qualitative studyOriginal Research · 2026